CN110897993A - 一种外泌体冻干粉的制备方法及其应用 - Google Patents
一种外泌体冻干粉的制备方法及其应用 Download PDFInfo
- Publication number
- CN110897993A CN110897993A CN201811072844.1A CN201811072844A CN110897993A CN 110897993 A CN110897993 A CN 110897993A CN 201811072844 A CN201811072844 A CN 201811072844A CN 110897993 A CN110897993 A CN 110897993A
- Authority
- CN
- China
- Prior art keywords
- exosome
- dried powder
- freeze
- temperature
- freezing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 169
- 239000000843 powder Substances 0.000 title claims abstract description 76
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 238000007710 freezing Methods 0.000 claims abstract description 46
- 230000008014 freezing Effects 0.000 claims abstract description 46
- 238000001035 drying Methods 0.000 claims abstract description 42
- 239000003223 protective agent Substances 0.000 claims abstract description 26
- 238000003756 stirring Methods 0.000 claims abstract description 26
- 238000000859 sublimation Methods 0.000 claims abstract description 26
- 230000008022 sublimation Effects 0.000 claims abstract description 26
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 24
- 239000012498 ultrapure water Substances 0.000 claims abstract description 24
- 239000000243 solution Substances 0.000 claims abstract description 23
- 239000011259 mixed solution Substances 0.000 claims abstract description 20
- 239000000654 additive Substances 0.000 claims abstract description 10
- 230000000996 additive effect Effects 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 238000005728 strengthening Methods 0.000 claims abstract description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 50
- 229920002674 hyaluronan Polymers 0.000 claims description 50
- 229960003160 hyaluronic acid Drugs 0.000 claims description 50
- 239000011550 stock solution Substances 0.000 claims description 50
- 238000005303 weighing Methods 0.000 claims description 27
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 20
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 20
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 20
- 238000001816 cooling Methods 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 238000011049 filling Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 9
- 229930195725 Mannitol Natural products 0.000 claims description 9
- 230000002708 enhancing effect Effects 0.000 claims description 9
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims description 9
- 239000000594 mannitol Substances 0.000 claims description 9
- 235000010355 mannitol Nutrition 0.000 claims description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- 229920002307 Dextran Polymers 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 238000003795 desorption Methods 0.000 claims description 6
- 239000008101 lactose Substances 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 150000005846 sugar alcohols Polymers 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 210000004027 cell Anatomy 0.000 abstract description 12
- 210000003491 skin Anatomy 0.000 abstract description 12
- 238000003860 storage Methods 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 8
- 230000037303 wrinkles Effects 0.000 abstract description 6
- 230000033115 angiogenesis Effects 0.000 abstract description 5
- 210000004927 skin cell Anatomy 0.000 abstract description 5
- 102000008186 Collagen Human genes 0.000 abstract description 4
- 108010035532 Collagen Proteins 0.000 abstract description 4
- 230000003796 beauty Effects 0.000 abstract description 4
- 229920001436 collagen Polymers 0.000 abstract description 4
- 210000004207 dermis Anatomy 0.000 abstract description 4
- 210000002919 epithelial cell Anatomy 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 230000035755 proliferation Effects 0.000 abstract description 4
- 230000008929 regeneration Effects 0.000 abstract description 4
- 238000011069 regeneration method Methods 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000009759 skin aging Effects 0.000 abstract description 4
- 230000002087 whitening effect Effects 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 3
- 238000009499 grossing Methods 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000004952 protein activity Effects 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000000463 material Substances 0.000 description 18
- 238000004108 freeze drying Methods 0.000 description 17
- 230000001965 increasing effect Effects 0.000 description 16
- 230000008569 process Effects 0.000 description 11
- 230000000975 bioactive effect Effects 0.000 description 10
- 239000013078 crystal Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000001681 protective effect Effects 0.000 description 6
- 210000000130 stem cell Anatomy 0.000 description 6
- 210000004127 vitreous body Anatomy 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 4
- 210000003954 umbilical cord Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 229940119744 dextran 40 Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000003508 chemical denaturation Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 150000002840 non-reducing disaccharides Chemical class 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000005092 sublimation method Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000004781 supercooling Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811072844.1A CN110897993A (zh) | 2018-09-14 | 2018-09-14 | 一种外泌体冻干粉的制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811072844.1A CN110897993A (zh) | 2018-09-14 | 2018-09-14 | 一种外泌体冻干粉的制备方法及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110897993A true CN110897993A (zh) | 2020-03-24 |
Family
ID=69813251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811072844.1A Withdrawn CN110897993A (zh) | 2018-09-14 | 2018-09-14 | 一种外泌体冻干粉的制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110897993A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112451488A (zh) * | 2020-12-15 | 2021-03-09 | 南京中医药大学 | 一种植物来源类外泌体制品的制备方法和应用 |
CN112626268A (zh) * | 2020-12-18 | 2021-04-09 | 上海捷诺圣华生物科技有限公司 | 一种检测新冠病毒冻干粉剂的制备工艺 |
CN113018245A (zh) * | 2021-03-15 | 2021-06-25 | 广州赛莱拉生物基因工程有限公司 | 一种牛胎盘细胞外泌体冻干粉及其制备方法 |
CN113171332A (zh) * | 2021-03-18 | 2021-07-27 | 深圳玄鸟生物科技有限公司 | 一种外泌体冻干粉、其制备方法及护肤品 |
CN113197834A (zh) * | 2021-04-21 | 2021-08-03 | 河南瑞珀斯生物科技有限公司 | 一种美容护肤用干细胞外泌体冻干粉及其制备方法 |
CN115990261A (zh) * | 2021-10-20 | 2023-04-21 | 谛邈生物科技(北京)有限公司 | 外泌体冻干粉针剂或外泌体液体制剂的保护剂 |
CN116139023A (zh) * | 2023-02-14 | 2023-05-23 | 上海臻臣化妆品有限公司 | 粉类制品的制备方法、粉类制品及粉类产品 |
-
2018
- 2018-09-14 CN CN201811072844.1A patent/CN110897993A/zh not_active Withdrawn
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112451488A (zh) * | 2020-12-15 | 2021-03-09 | 南京中医药大学 | 一种植物来源类外泌体制品的制备方法和应用 |
CN112626268A (zh) * | 2020-12-18 | 2021-04-09 | 上海捷诺圣华生物科技有限公司 | 一种检测新冠病毒冻干粉剂的制备工艺 |
CN113018245A (zh) * | 2021-03-15 | 2021-06-25 | 广州赛莱拉生物基因工程有限公司 | 一种牛胎盘细胞外泌体冻干粉及其制备方法 |
CN113171332A (zh) * | 2021-03-18 | 2021-07-27 | 深圳玄鸟生物科技有限公司 | 一种外泌体冻干粉、其制备方法及护肤品 |
CN113197834A (zh) * | 2021-04-21 | 2021-08-03 | 河南瑞珀斯生物科技有限公司 | 一种美容护肤用干细胞外泌体冻干粉及其制备方法 |
CN115990261A (zh) * | 2021-10-20 | 2023-04-21 | 谛邈生物科技(北京)有限公司 | 外泌体冻干粉针剂或外泌体液体制剂的保护剂 |
CN115990261B (zh) * | 2021-10-20 | 2024-01-05 | 光武惠文生物科技(北京)有限公司 | 外泌体冻干粉针剂或外泌体液体制剂的保护剂 |
CN116139023A (zh) * | 2023-02-14 | 2023-05-23 | 上海臻臣化妆品有限公司 | 粉类制品的制备方法、粉类制品及粉类产品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110897993A (zh) | 一种外泌体冻干粉的制备方法及其应用 | |
CN102746372B (zh) | 一种细胞外基质冷冻干燥保护液及其使用方法 | |
BRPI0112638B1 (pt) | Meio de preservação e estocagem para materiais biológicos | |
CN101249043B (zh) | 人生长激素和人表皮生长因子组合物在美容中的应用 | |
JPH09504529A (ja) | 安定化したプロスタグランジンe▲下1▼ | |
CN1994461A (zh) | 一种制备注射用还原型谷胱甘肽的冻干工艺 | |
WO2019028976A1 (zh) | 耐热保护剂、猪瘟可室温保存活疫苗及其制备方法和应用 | |
CN110590932A (zh) | 一种脐带间充质干细胞因子冻干粉的制备方法 | |
CN101984978B (zh) | 一种复合辅酶药的制备方法 | |
CN103204958A (zh) | 一种低乙醇残留的那曲肝素钙生产工艺 | |
CN107802604A (zh) | 一种双辅料注射用拉氧头孢钠冻干粉针剂 | |
CN103585018A (zh) | 一种注射用还原型谷胱甘肽的新冻干方法 | |
CN109097325A (zh) | 一种用于美容保养的脂肪干细胞液的制备方法 | |
CN115968867A (zh) | 外泌体冻干保护剂和外泌体冻干制剂的制备方法 | |
CN104173299A (zh) | 一种注射用盐酸川芎嗪的冷冻干燥方法 | |
CN115177547A (zh) | 一种具有修复功能的miRNA冻干保护剂及其冻干球制备方法 | |
CN116211891A (zh) | 一种人间充质干细胞条件培养液冻干粉制剂及其制备方法 | |
CN102784173A (zh) | 一种冬虫夏草冻干粉的制备方法 | |
CN114470171A (zh) | 胶原蛋白脂质体冻干乳及其制备方法 | |
CN103520192B (zh) | 一种注射用转化糖冻干粉针制剂制备方法 | |
CN111419804A (zh) | 一种注射用血管生成抑肽冻干制剂及其冻干方法 | |
CN112485451A (zh) | 一种白介素6冻干校准品及其制备方法与冻干保护液 | |
CN114832093A (zh) | 一种含有细胞生长因子的冻干粉及其制备方法 | |
CN115381825B (zh) | 一种尼可地尔药物组合物及其制备方法 | |
CN103230371B (zh) | 注射用奥沙利铂冻干制剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200312 Address after: 710024 floor 4, building B1, standard workshop community, No. 599, Fangyuan Third Road, modern textile industrial park, Baqiao District, Xi'an City, Shaanxi Province Applicant after: Xi'an Bohong Biotechnology Co., Ltd Address before: 710024 B1 3-4 layer of standard workshop District of Baqiao District Textile Industrial Park, Xi'an City, Shaanxi Applicant before: Shaanxi Bo Bo Biological Technology Group Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200324 |
|
WW01 | Invention patent application withdrawn after publication |